Our findings show that MMDD suppressed α-SMA expression, a marker of fibroblast activation, in IPF mice and concurrently reduced Collagen I, vimentin, and hydroxyproline levels, indicating that MMDD’s therapeutic effect in IPF is closely linked to modulation of fibroblast activity. Here, VIM is linked to idiopathic pulmonary fibrosis.